<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
   xmlns:content="http://purl.org/rss/1.0/modules/content/"
   xmlns:dc="http://purl.org/dc/elements/1.1/"
   xmlns:atom="http://www.w3.org/2005/Atom"
   xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
   xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
   xmlns:company="http://purl.org/rss/1.0/modules/company"
>
	<channel>
		<title>Latest News - Market Wire News</title>
		<atom:link href="https://marketwirenews.com/rss/news-releases/?s=crmd" rel="self" type="application/rss+xml" />
		<link>https://marketwirenews.com</link>
		<description>Market Wire News RSS News Feed for CorMedix Inc. (NASDAQ: CRMD)</description>
		<lastBuildDate>Thu, 08 Oct 2026 13:07:57 -0400</lastBuildDate>
		<language>en-US</language>
		<sy:updatePeriod> hourly </sy:updatePeriod>
		<sy:updateFrequency> 60 </sy:updateFrequency>

		<image>
			<url>https://marketwirenews.com/assets/img/icons/favicon-32x32.png</url>
			<title>Market Wire News</title>
			<link>https://marketwirenews.com</link>
			<width>32</width>
			<height>32</height>
		</image>
		<item>
            <title>Market Wire News Hottest Alerts Newsletter</title>
            <link>https://marketwirenews.com/newsletter/</link>
            <pubDate>Thu, 08 Oct 2026 13:07:57 -0400</pubDate>
            <dc:creator><![CDATA[Market Wire News]]></dc:creator>
            <category><![CDATA[Stock Picks]]></category>
            <category><![CDATA[Stock ALerts]]></category>
            <description><![CDATA[Subscribe to Market Wire News newsletter for instant real-time stock alerts, breaking financial news, trending stocks, and portfolio updates delivered to your email & mobile.]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/newsletter/?v=1821</guid>
          </item>
          <item>
            <title>Market Wire News Trending Stocks</title>
            <link>https://marketwirenews.com/trending-stocks/</link>
            <pubDate>Thu, 08 Oct 2026 13:07:57 -0400</pubDate>
            <dc:creator><![CDATA[Market Wire News]]></dc:creator>
            <category><![CDATA[Stock Picks]]></category>
            <category><![CDATA[Stock ALerts]]></category>
            <description><![CDATA[Track today's hottest trending stocks on NASDAQ, NYSE, OTCMKTS & Canadian markets. See massive % gainers, real-time movers, volumes, and linked breaking news updates.]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/trending-stocks/?v=1821</guid>
          </item>
          <item>
            <title>Market Wire News Investor Awarenewss</title>
            <link>https://marketwirenews.com/advertise/</link>
            <pubDate>Thu, 08 Oct 2026 13:07:57 -0400</pubDate>
            <dc:creator><![CDATA[Market Wire News]]></dc:creator>
            <category><![CDATA[Invesor Awareness]]></category>
            <category><![CDATA[Investor Releatios]]></category>
            <description><![CDATA[Stock Promoter, Investor Relations, Investor Awareness, Market Wire News, investor brand advertisement services, plans and pricing.]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/advertise/?v=1821</guid>
          </item>
		<item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews September 01, 2026 08:30:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-therapeutics-to-participate-in-the-wells-fa-8125694013811462.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 01 Sep 2026 08:30:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[PARSIPPANY, N.J., Sept. 01, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that senior management will be participating in a fir...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-therapeutics-to-participate-in-the-wells-fa-8125694013811462.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews June 08, 2026 08:30:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/u-s-court-of-appeals-for-the-federal-circuit-affirms-5846001116478042.html?utm_source=rss-news-releases</link>
            <pubDate>Mon, 08 Jun 2026 08:30:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[PARSIPPANY, N.J., June 08, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that the United States Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District Court for the Northern District of Illinois that the patents covering its product...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/u-s-court-of-appeals-for-the-federal-circuit-affirms-5846001116478042.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews May 15, 2026 08:30:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-therapeutics-to-participate-in-two-upcoming-5933305812266531.html?utm_source=rss-news-releases</link>
            <pubDate>Fri, 15 May 2026 08:30:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[PARSIPPANY, N.J., May 15, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that management will be participating in fireside chats and investor meetings at both the RBC Capital Markets Global Healthcare Conference being held in New York on May 19 &#x2013; 20, 2026 and...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-therapeutics-to-participate-in-two-upcoming-5933305812266531.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews May 14, 2026 07:30:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-therapeutics-reports-first-quarter-2026-fin-5614100954916555.html?utm_source=rss-news-releases</link>
            <pubDate>Thu, 14 May 2026 07:30:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[&#x2012; Q1 2026 Net Revenue of&#xA0;  $127.4 million   &#x2012;     &#x2012; Q1 2026 Net Income of   $38.6 million  ; Adjusted EBITDA of   $70.0 million   &#x2012;     &#x2012;   Company raises FY 2026 Revenue and Adjusted EBITDA Guidance   &#x2012;     &#x2012; Conference Call Scheduled for Tod...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-therapeutics-reports-first-quarter-2026-fin-5614100954916555.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews May 05, 2026 08:30:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-therapeutics-to-report-first-quarter-2026-f-8400362901921666.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 05 May 2026 08:30:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[PARSIPPANY, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that it will report its financial results for the first quarter ended March 31, 2026, before the market opens on Thursday, May 14, 2026, and will host a corporate update conference call at 8:30...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-therapeutics-to-report-first-quarter-2026-f-8400362901921666.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews April 27, 2026 07:30:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-therapeutics-announces-positive-topline-res-6832769701800952.html?utm_source=rss-news-releases</link>
            <pubDate>Mon, 27 Apr 2026 07:30:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[&#x2013; The study primary endpoint was met, showing non-inferiority vs. standard antimicrobial regimen in fungal free survival at Day 90 &#x2013;   &#x2013; Study showed favorable benefit for toxicity related discontinuations and drug-drug interactions &#x2013;   &#x2013; Rezafungin was well tol...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-therapeutics-announces-positive-topline-res-6832769701800952.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews April 07, 2026 08:30:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-to-participate-in-needham-virtual-healthcar-8439425777346705.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 07 Apr 2026 08:30:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[PARSIPPANY, N.J., April 07, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that senior management will be participating in a fir...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-to-participate-in-needham-virtual-healthcar-8439425777346705.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews March 05, 2026 07:30:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-inc-reports-fourth-quarter-and-full-year-20-6291978873034489.html?utm_source=rss-news-releases</link>
            <pubDate>Thu, 05 Mar 2026 07:30:00 -0500</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[&#x2012; Q4 2025 Net Revenue of $128.6 million &#x2012;     &#x2012; Pro Forma Full Year 2025 Net Revenue of $401.3 million &#x2012; &#xA0;&#xA0;    &#x2012; Q4 2025 Net Income of $14.0 million; Adjusted EBITDA of $77.2 million &#x2012;     &#x2012; Conference Call Scheduled for Today at 8:30 a.m...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-inc-reports-fourth-quarter-and-full-year-20-6291978873034489.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews March 02, 2026 08:30:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-inc-to-report-fourth-quarter-and-full-year--5523477921468477.html?utm_source=rss-news-releases</link>
            <pubDate>Mon, 02 Mar 2026 08:30:00 -0500</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[BERKELEY HEIGHTS, N.J., March 02, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that it will report its financial results for t...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-inc-to-report-fourth-quarter-and-full-year--5523477921468477.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews February 02, 2026 08:30:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-therapeutics-announces-share-repurchase-pro-7430097883793594.html?utm_source=rss-news-releases</link>
            <pubDate>Mon, 02 Feb 2026 08:30:00 -0500</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[BERKELEY HEIGHTS, N.J., Feb. 02, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced its Board of Directors has approved a share repu...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-therapeutics-announces-share-repurchase-pro-7430097883793594.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews January 29, 2026 08:30:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-therapeutics-to-host-in-person-and-virtual--8497607785278812.html?utm_source=rss-news-releases</link>
            <pubDate>Thu, 29 Jan 2026 08:30:00 -0500</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[BERKELEY HEIGHTS, N.J., Jan. 29, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that it will host an in-person and virtual analy...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-therapeutics-to-host-in-person-and-virtual--8497607785278812.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews January 14, 2026 09:58:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/lost-money-on-cormedix-inc-crmd-contact-levi-korsins-8809100305337174.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 14 Jan 2026 09:58:00 -0500</pubDate>
            <dc:creator><![CDATA[Newsfile]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[New York, New York--(Newsfile Corp. - January 14, 2026) - Levi &amp; Korsinsky notifies investors that it has commenced an investigation into CorMedix Inc. ("CorMedix Inc.") (NASDAQ: CRMD) concerning potential violations of the federal securities laws.  On January 8, 2026, before the market opene...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/lost-money-on-cormedix-inc-crmd-contact-levi-korsins-8809100305337174.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews January 09, 2026 08:30:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-therapeutics-to-present-at-the-44th-annual--6378601530092520.html?utm_source=rss-news-releases</link>
            <pubDate>Fri, 09 Jan 2026 08:30:00 -0500</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[BERKELEY HEIGHTS, N.J., Jan. 09, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that Joseph Todisco, Chairman and CEO of CorMedi...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-therapeutics-to-present-at-the-44th-annual--6378601530092520.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews January 08, 2026 08:05:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-therapeutics-announces-leadership-and-board-7436741337901481.html?utm_source=rss-news-releases</link>
            <pubDate>Thu, 08 Jan 2026 08:05:00 -0500</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[BERKELEY HEIGHTS, N.J., Jan. 08, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced an addition to its executive leadership team and...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-therapeutics-announces-leadership-and-board-7436741337901481.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews January 08, 2026 08:00:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-therapeutics-announces-preliminary-fourth-q-7984064401566810.html?utm_source=rss-news-releases</link>
            <pubDate>Thu, 08 Jan 2026 08:00:00 -0500</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[&#x2012; Q4 2025 Unaudited Net Revenue of Approximately $127 million &#x2012;     &#x2012; FY 2025 Unaudited Pro Forma Net Revenue of Approximately $400 million &#x2012;     &#x2012; Expects Q4 Adjusted EBITDA of Between $77 million and $81 million &#x2012;     &#x2012; Unaudited Cash and Short-t...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-therapeutics-announces-preliminary-fourth-q-7984064401566810.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews December 18, 2025 08:00:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-therapeutics-announces-positive-data-from-o-5957176394326842.html?utm_source=rss-news-releases</link>
            <pubDate>Thu, 18 Dec 2025 08:00:00 -0500</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[BERKELEY HEIGHTS, N.J., Dec. 18, 2025 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced interim results for the Company&#x2019;s ongoing...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-therapeutics-announces-positive-data-from-o-5957176394326842.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews November 12, 2025 04:05:00 pm</title>
            <link>https://marketwirenews.com/stock/crmd/news/talphera-announces-third-quarter-2025-financial-resu-8280823473199982.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 12 Nov 2025 16:05:00 -0500</pubDate>
            <dc:creator><![CDATA[PR Newswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update         PR Newswire        Closed  $17 million  first tranche financing led by a strategic investment from CorMedix, Inc.      Cash and investments at  September 30, 2025  were  $21.3 million ; combined with con...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/talphera-announces-third-quarter-2025-financial-resu-8280823473199982.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews November 12, 2025 11:00:36 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/strong-earnings-and-biotech-resilience-define-the-mi-6528987080467900.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 12 Nov 2025 11:00:36 -0500</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[DENVER, Nov. 12, 2025 (GLOBE NEWSWIRE) --       Kraig Labs (OTCQB: KBLB) Spins the Future &#x2014; Decades of Failure Give Way to a Commercial Breakthrough       After decades of failed attempts by corporate giants and research consortia across the globe,   Kraig Biocraft Laboratories (OTCQB: KBL...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/strong-earnings-and-biotech-resilience-define-the-mi-6528987080467900.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews November 12, 2025 07:30:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-inc-reports-third-quarter-2025-financial-re-5776956360500711.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 12 Nov 2025 07:30:00 -0500</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[&#x2012; Q3 2025 Net Revenue of $104.3 million; Pro Forma Net Revenue of $130.8 million &#x2012;         &#x2012; Q3 2025 Net Income of $108.6 million; Adjusted EBITDA of $71.9 million &#x2012;         &#x2012; FY 2025 Pro Forma Net Revenue Guidance Raised to a Range of $390 to $410 million &#x20...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-inc-reports-third-quarter-2025-financial-re-5776956360500711.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews October 31, 2025 08:30:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-inc-to-report-third-quarter-2025-financial--7421116938151602.html?utm_source=rss-news-releases</link>
            <pubDate>Fri, 31 Oct 2025 08:30:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[BERKELEY HEIGHTS, N.J., Oct. 31, 2025 (GLOBE NEWSWIRE) --   CorMedix Inc.   (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that it will report its financial results for the th...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-inc-to-report-third-quarter-2025-financial--7421116938151602.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews October 23, 2025 08:30:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-inc-receives-innovative-technology-designat-8359370105551129.html?utm_source=rss-news-releases</link>
            <pubDate>Thu, 23 Oct 2025 08:30:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[BERKELEY HEIGHTS, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that DefenCath has received an Innovative Technology des...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-inc-receives-innovative-technology-designat-8359370105551129.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews October 22, 2025 04:05:00 pm</title>
            <link>https://marketwirenews.com/stock/crmd/news/halper-sadeh-llc-encourages-cormedix-inc-shareholder-4837096771614125.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 22 Oct 2025 16:05:00 -0400</pubDate>
            <dc:creator><![CDATA[Business Wire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[Shareholders should contact the firm immediately as there may be limited time to enforce your rights.               Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of CorMedix Inc. (NASDAQ: CRMD) breached their fiduciary duties to shareholder...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/halper-sadeh-llc-encourages-cormedix-inc-shareholder-4837096771614125.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews October 21, 2025 08:30:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/talphera-announces-the-appointment-of-joe-todisco-to-4699851714033219.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 21 Oct 2025 08:30:00 -0400</pubDate>
            <dc:creator><![CDATA[PR Newswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[Talphera Announces the Appointment of Joe Todisco to Board of Directors         PR Newswire         SAN MATEO, Calif.  ,   Oct. 21, 2025   /PRNewswire/ -- Talphera, Inc.&#xA0;(Nasdaq: TLPH), (Talphera), a specialty pharmaceutical company focused on the development and commercialization of innovat...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/talphera-announces-the-appointment-of-joe-todisco-to-4699851714033219.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews October 20, 2025 07:30:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-inc-announces-preliminary-third-quarter-202-8247742675590446.html?utm_source=rss-news-releases</link>
            <pubDate>Mon, 20 Oct 2025 07:30:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[&#x2012; Q3 2025 Unaudited Pro Forma Net Revenue of more than $125 million &#x2012;         &#x2012; Q3 2025 Unaudited DefenCath Net Revenue of more than $85 million &#x2012;         &#x2012; Raising FY 2025 Pro Forma Net Revenue Guidance to at least $375 million &#x2012;         &#x2012; ~$30mm ...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-inc-announces-preliminary-third-quarter-202-8247742675590446.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews September 29, 2025 08:30:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-announces-completion-of-enrollment-in-phase-6645576999431620.html?utm_source=rss-news-releases</link>
            <pubDate>Mon, 29 Sep 2025 08:30:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[- Enrollment Completed in Ongoing Phase III ReSPECT Study in Prophylaxis of Fungal Infections in Adult Patients Undergoing Allogeneic Blood and Marrow Transplant -     - Topline Results from ReSPECT Study Expected in 2Q 2026 -     BERKELEY HEIGHTS, N.J., Sept. 29, 2025 (GLOBE NEWSWIRE) -- CorMedi...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-announces-completion-of-enrollment-in-phase-6645576999431620.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews September 08, 2025 08:30:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-announces-strategic-minority-investment-in--5978977815872478.html?utm_source=rss-news-releases</link>
            <pubDate>Mon, 08 Sep 2025 08:30:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[BERKELEY HEIGHTS, N.J., Sept. 08, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (&#x201C;CorMedix&#x201D;) (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that it has made a $5 millio...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-announces-strategic-minority-investment-in--5978977815872478.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews September 08, 2025 08:30:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/talphera-announces-private-placement-financing-of-up-6369803751859584.html?utm_source=rss-news-releases</link>
            <pubDate>Mon, 08 Sep 2025 08:30:00 -0400</pubDate>
            <dc:creator><![CDATA[PR Newswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market           PR Newswire           CorMedix is making a strategic investment in Talphera as the lead investor, supported by existing stockholders Nantahala, Rosalind and Rock Springs with several new institution...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/talphera-announces-private-placement-financing-of-up-6369803751859584.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews September 02, 2025 07:30:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-completes-acquisition-of-melinta-therapeuti-8542409567795060.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 02 Sep 2025 07:30:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[- Transformational deal for CorMedix that expands and diversifies company&#x2019;s commercial product portfolio, with seven innovative drug products and a pipeline expansion indication with near-term revenue growth potential -         - Revised guidance of pro forma 2025 combined revenues, now es...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-completes-acquisition-of-melinta-therapeuti-8542409567795060.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews August 28, 2025 08:30:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-to-participate-in-upcoming-investor-confere-7493854619769450.html?utm_source=rss-news-releases</link>
            <pubDate>Thu, 28 Aug 2025 08:30:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[BERKELEY HEIGHTS, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (&#x201C;CorMedix&#x201D;) (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that senior management will b...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-to-participate-in-upcoming-investor-confere-7493854619769450.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews August 07, 2025 07:00:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-to-acquire-melinta-therapeutics-creating-di-8808619956145431.html?utm_source=rss-news-releases</link>
            <pubDate>Thu, 07 Aug 2025 07:00:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[Transformational deal for CorMedix that expands and diversifies company&#x2019;s commercial product portfolio, with seven innovative drug products and a pipeline expansion indication with near-term revenue growth potential         Transaction expected to be near-term accretive to EPS with double-...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-to-acquire-melinta-therapeutics-creating-di-8808619956145431.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews August 07, 2025 07:00:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-inc-reports-second-quarter-2025-financial-r-8934823289708036.html?utm_source=rss-news-releases</link>
            <pubDate>Thu, 07 Aug 2025 07:00:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[&#x2012; Q2 2025 Net Revenue of $39.7mm; Net Income of $19.8mm; Adjusted EBITDA of $22.4mm &#x2012;         &#x2012; Company Announces Acquisition of Melinta Therapeutics &#x2012;         &#x2012; Conference Call Scheduled for Today at 8:30 a.m. Eastern Time &#x2012;       BERKELEY HEIGHTS, N.J.,...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-inc-reports-second-quarter-2025-financial-r-8934823289708036.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews June 27, 2025 08:00:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-inc-announces-pricing-of-public-offering-of-6345051554843830.html?utm_source=rss-news-releases</link>
            <pubDate>Fri, 27 Jun 2025 08:00:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[BERKELEY HEIGHTS, N.J., June 27, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced the pricing of its previously announced underwritten pub...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-inc-announces-pricing-of-public-offering-of-6345051554843830.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews June 26, 2025 04:01:00 pm</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-inc-announces-proposed-public-offering-of-c-6026264022882140.html?utm_source=rss-news-releases</link>
            <pubDate>Thu, 26 Jun 2025 16:01:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[BERKELEY HEIGHTS, N.J., June 26, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that it intends to offer and sell $85.0 million of share...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-inc-announces-proposed-public-offering-of-c-6026264022882140.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews June 23, 2025 07:30:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-inc-announces-customer-implementation-5923825329626824.html?utm_source=rss-news-releases</link>
            <pubDate>Mon, 23 Jun 2025 07:30:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[BERKELEY HEIGHTS, N.J., June 23, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announces an update related to its Large Dialysis Organization (LD...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-inc-announces-customer-implementation-5923825329626824.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews May 30, 2025 08:30:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-inc-to-participate-in-the-jefferies-global--6756620944368714.html?utm_source=rss-news-releases</link>
            <pubDate>Fri, 30 May 2025 08:30:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[BERKELEY HEIGHTS, N.J., May 30, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, will be participating in the Jefferies Global Healthcare Conference, taki...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-inc-to-participate-in-the-jefferies-global--6756620944368714.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews May 15, 2025 08:30:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-inc-to-participate-in-the-rbc-global-health-7509273234269093.html?utm_source=rss-news-releases</link>
            <pubDate>Thu, 15 May 2025 08:30:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[BERKELEY HEIGHTS, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, will be participating in the RBC Capital Markets Global Healthcare Confer...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-inc-to-participate-in-the-rbc-global-health-7509273234269093.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews April 29, 2025 08:30:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-inc-to-report-first-quarter-2025-financial--5134007734143422.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 29 Apr 2025 08:30:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[BERKELEY HEIGHTS, N.J., April 29, 2025 (GLOBE NEWSWIRE) --   CorMedix Inc.   (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that it will report its financial results for the f...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-inc-to-report-first-quarter-2025-financial--5134007734143422.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews April 08, 2025 07:30:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-inc-announces-preliminary-first-quarter-202-8544173763121379.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 08 Apr 2025 07:30:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[&#x2012; Q1 2025 Unaudited Net Revenue of $39.0 million &#x2012;         &#x2012; Expected Q1 Adjusted EBITDA above $22.5 million &#x2012;         &#x2012; Q1 2025 Cash and Cash Equivalents of Approximately $77.5 million &#x2012;       BERKELEY HEIGHTS, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- Co...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-inc-announces-preliminary-first-quarter-202-8544173763121379.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews April 02, 2025 08:30:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-inc-to-participate-in-the-24th-annual-needh-6780249301644594.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 02 Apr 2025 08:30:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[BERKELEY HEIGHTS, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that management will be participating in the 24   th   ...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-inc-to-participate-in-the-24th-annual-needh-6780249301644594.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews March 25, 2025 07:30:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-inc-reports-fourth-quarter-and-full-year-20-5193723755001484.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 25 Mar 2025 07:30:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[&#x2012; Q4 2024 Net Revenue of $31.2mm; 2024 Net Revenue of $43.5mm &#x2012;         &#x2012; Q4 Net Income of $13.5mm and Adjusted EBITDA of $15.3mm &#x2012;         &#x2012; Conference Call Scheduled for Today at 8:30 a.m. Eastern Time &#x2012;       BERKELEY HEIGHTS, N.J., March 25, 2025 (GLO...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-inc-reports-fourth-quarter-and-full-year-20-5193723755001484.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews March 18, 2025 08:30:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-inc-to-report-fourth-quarter-and-full-year--6607045780547151.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 18 Mar 2025 08:30:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[BERKELEY HEIGHTS, N.J., March 18, 2025 (GLOBE NEWSWIRE) --   CorMedix Inc.   (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that it will report its financial results for the f...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-inc-to-report-fourth-quarter-and-full-year--6607045780547151.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews January 21, 2025 08:00:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-announces-collaboration-for-defencath-promo-6808549285312820.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 21 Jan 2025 08:00:00 -0500</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[BERKELEY HEIGHTS, N.J., Jan. 21, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announces it has engaged with WSI PBG, a subsidiary of Golden Stat...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-announces-collaboration-for-defencath-promo-6808549285312820.html?s=crmd?v=<?php echo 1821;?></guid>
            </item><item>
            <title>$CRMD CorMedix Inc #MWN #BreakingNews January 07, 2025 07:30:00 am</title>
            <link>https://marketwirenews.com/stock/crmd/news/cormedix-inc-announces-preliminary-fourth-quarter-20-6717222864940309.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 07 Jan 2025 07:30:00 -0500</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[CRMD]]></category>
            <category><![CDATA[CorMedix Inc.]]></category>
            <description><![CDATA[&#x2012; Q4 2024 Unaudited Net Revenue of Approximately $31mm &#x2012;         &#x2012; FY 2024 Unaudited Net Revenue of Approximately $43mm &#x2012;         &#x2012; Expects Q4 Adjusted EBITDA to Exceed $12mm &#x2012;       BERKELEY HEIGHTS, N.J., Jan. 07, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. ...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crmd/news/cormedix-inc-announces-preliminary-fourth-quarter-20-6717222864940309.html?s=crmd?v=<?php echo 1821;?></guid>
            </item>
	</channel>
</rss>